Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning—An Artificial Intelligence Concept

Open access
Abajian, Aaron, Murali, Nikitha, Savic, Lynn Jeanette, Laage-Gaupp, Fabian Max, Nezami, Nariman, Duncan, James S., Schlachter, Todd, Lin, MingDe, Geschwind, Jean-François, Chapiro, Julius · 2018 · Journal of Vascular and Interventional Radiology

Abstract

Purpose To use magnetic resonance (MR) imaging and clinical patient data to create an artificial intelligence (AI) framework for the prediction of therapeutic outcomes of trans-arterial chemoembolization (TACE) by applying machine learning (ML) techniques. Methods This study included 36 patients with hepatocellular carcinoma (HCC) treated with TACE. The cohort (age 62 ± 8.9 years [mean ± standard deviation]) contained 31 males; 13 white; Eastern Cooperative Oncology Group Performance Status: 0–24, 1–10, 2–2; Child-Pugh: A-31, B-4, C-1; Barcelona Clinic Liver Cancer Stage: 0–1, A-12, B-10, C-13; tumor size 5.2 ± 3.0cm; number of tumors 2.6 ± 1.1; TACE: 30 conventional, 6 with drug-eluting embolic agents. MR imaging was obtained prior to and one month after TACE. Image-based tumor response to TACE was assessed using the 3D quantitative European Association for the Study of the Liver (qEASL) criteria. Clinical information, baseline imaging, and therapeutic features were used to train logistic regression (LR) and random forest (RF) models to predict patients as treatment responders or non-responders. The performance of the models was compared to treatment response as determined by qEASL response criteria using leave-one-out cross-validation. Results Both LR and RF models predicted TACE treatment response with an overall accuracy of 78% (sensitivity 62.5%, specificity 82.1%, positive predictive value 50.0%, negative predictive value 88.5%). The strongest predictors of treatment response included a clinical variable (presence of cirrhosis) and an imaging variable (tumor signal intensity >27.0). Conclusions TACE outcomes in patients with HCC may be predicted pre-procedurally by combining clinical patient data with baseline MR imaging using AI and ML techniques.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jvir.2018.01.769

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 175

Metadata

Authors
Abajian, A., Murali, N., Savic, L. J., Laage-Gaupp, F. M., Nezami, N., Duncan, J. S., Schlachter, T., Lin, M., Geschwind, J.-F., & Chapiro, J.
Venue
Journal of Vascular and Interventional Radiology
Publisher
Elsevier BV
Published
2018-06
Volume
29
Issue
6
Pages
850-857.e1
ISSN
1051-0443 (ISSN-L)
OpenAlex
W2794404680
Cited by
175
References
2
FWCI
10.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning—An Artificial Intelligence Concept. https://app.cochat.ai/papers/10.1016/j.jvir.2018.01.769
The paper
Abajian, A., Murali, N., Savic, L. J., Laage-Gaupp, F. M., Nezami, N., Duncan, J. S., Schlachter, T., Lin, M., Geschwind, J.-F., & Chapiro, J. (2018). Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning—An Artificial Intelligence Concept. Journal of Vascular and Interventional Radiology. https://doi.org/10.1016/j.jvir.2018.01.769

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.